Pulmonary Nodule Localization Prospective Validation

Last updated: January 23, 2021
Sponsor: E-DA Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pulmonary Nodules

Treatment

N/A

Clinical Study ID

NCT04690790
EMRP56109N
  • Ages > 20
  • All Genders

Study Summary

Localization is the key for successful excision of small target nodules under thoracoscopy, but the procedure also brings risks to patients. However, the criteria is still unclear. The investigators will validate the prediction model produced by institutional retrospective analysis in the prospective cohort.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age ≧ 20 years
  • Lung nodule size ≦2cm on the pre-operative computed tomography (CT)
  • Nodulectomy is performed under thoracoscopy

Exclusion

Exclusion Criteria:

  • Age < 20 years
  • Lung nodule size > 2cm on CT or in the final pathology report
  • Open surgery for nodulectomy

Study Design

Total Participants: 50
Study Start date:
January 23, 2021
Estimated Completion Date:
December 31, 2021

Study Description

Excision of targeted lung nodules during thoracoscopy sometimes needs placing a mark before surgery. The procedure of mark placement (localization) could probably cause damages to the patients. However, the criteria for patient selection is still not clear. Through respective analysis, the investigators have set up a prediction model and wish to validate this model prospectively.

Connect with a study center

  • E-DA Hospital

    Kaohsiung, 824
    Taiwan

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.